Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

CMS eases regulations for COVID-19 response

CMS is allowing healthcare providers to react to the COVID-19 pandemic with greater flexibility by loosening some federal requirements and issuing sweeping new rules.

Hypertension and COVID-19: 4 key things patients should know

What, exactly, do patients need to know about the relationship between hypertension and COVID-19?

TAVR outcomes worse than expected at 11% of US facilities

Transcatheter aortic valve replacement (TAVR) outcomes have been worse than expected for 11% of healthcare providers in the United States, according to a new analysis of data from 2015 to 2017.

Thumbnail

HHS accelerates clinical trials for COVID-19 vaccines

HHS is speeding up the development and manufacturing of COVID-19 vaccines by partnering with Johnson & Johnson-owned Janssen Research and Development and Moderna Therapeutics.

Thumbnail

EuroHeartCare 2020 canceled over COVID-19 concerns

The event was scheduled to occur June 4-6 in Seville, Spain. It has been rescheduled for June 17-19, 2021.

Thumbnail

For TAVR patients with AFib, antiplatelet medication linked to poorer outcomes

Oral anticoagulation medication can help minimize bleeding complications among AFib patients undergoing transcatheter aortic valve replacement (TAVR), according to new research out of Europe.

Thumbnail

Humana, Cigna waive out-of-pocket costs for members treated for COVID-19

Humana and Cigna both announced March 30 that consumers would not have to pay for treatment related to COVID-19-covered services.

Thumbnail

TAVR ‘viable and safe’ for patients with a bicuspid valve

Transcatheter aortic valve replacement (TAVR) procedures with a self-expanding artificial valve are “very viable and safe” for low-risk patients with a bicuspid aortic valve, according to new research that tracked the outcomes of 150 patients.